The MMP1 Gene Epidermolysis Bullosa Dystrophica Autosomal Recessive Modifier Genetic Test is a specialized diagnostic procedure conducted at DNA Labs UAE. Priced at 4400 AED, this test is designed to detect specific mutations in the MMP1 gene, which have been identified as modifiers in the severity of Epidermolysis Bullosa Dystrophica (EBD), an autosomal recessive disorder. EBD is a rare genetic condition characterized by the fragility of skin and mucous membranes, leading to blistering and erosions from minor trauma. The MMP1 gene plays a crucial role in the body's extracellular matrix, and mutations can influence the clinical outcome of individuals with EBD. By identifying the presence of these mutations, the test can provide valuable information for the management and treatment planning of affected individuals, potentially leading to more personalized and effective therapeutic strategies. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a significant step forward in the genetic understanding and management of Epidermolysis Bullosa Dystrophica.
The ITGA6 gene plays a crucial role in the development and maintenance of the skin and mucous membranes. Mutations in this gene are associated with a rare genetic disorder known as Epidermolysis Bullosa Junctionalis with Pyloric Atresia (EB-PA). This condition is characterized by fragile skin that blisters easily in response to minor injuries or friction, along with a congenital obstruction of the pyloric valve of the stomach, which can lead to severe feeding difficulties and require surgical intervention.
At DNA Labs UAE, a genetic test is available for individuals suspected of having EB-PA, targeting mutations in the ITGA6 gene. This test is vital for confirming the diagnosis, understanding the disease's severity, and guiding treatment and management decisions. The cost of the test is 4400 AED. Conducted in a state-of-the-art facility, the test involves analyzing the patient's DNA to identify mutations in the ITGA6 gene that are indicative of Epidermolysis Bullosa Junctionalis with Pyloric Atresia. Results from this test can provide crucial information for affected families regarding prognosis, potential complications, and the risk of recurrence in future pregnancies.
The ITGB4 gene plays a crucial role in the development and stability of the skin and mucous membranes. Mutations in this gene can lead to a rare condition known as junctional epidermolysis bullosa with pyloric atresia (EB-PA), characterized by fragile skin that blisters easily and obstruction of the pylorus, the passage from the stomach to the small intestine. This can result in severe complications, making early and accurate diagnosis vital for managing the condition.
DNA Labs UAE offers a specialized genetic test aimed at detecting mutations in the ITGB4 gene to confirm a diagnosis of EB-PA. This test is crucial for families with a history of the condition or where there is clinical suspicion based on symptoms. By analyzing the patient's DNA, the test can identify specific genetic alterations responsible for the condition, providing essential information for treatment planning, management strategies, and genetic counseling.
The cost of the ITGB4 gene test for epidermolysis bullosa junctionalis with pyloric atresia at DNA Labs UAE is 4400 AED. This investment can be invaluable for affected families, offering them a clear diagnosis and the possibility to explore treatment options and prepare for any necessary medical interventions early on.
The KRT5 gene plays a crucial role in the health and integrity of the skin. Mutations in this gene are associated with Epidermolysis Bullosa Simplex (EBS), a group of genetic conditions characterized by fragile skin that blisters easily from minor injuries or friction. EBS can vary in severity, ranging from mild cases with localized blistering to more severe forms affecting larger areas of the body.
DNA Labs UAE offers a specialized genetic test to identify mutations in the KRT5 gene, helping to diagnose Epidermolysis Bullosa Simplex. This test is vital for individuals who exhibit symptoms of EBS or have a family history of the condition, as it can confirm the diagnosis and guide management and treatment strategies. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for specific mutations in the KRT5 gene.
The cost of the KRT5 Gene Epidermolysis Bullosa Simplex Genetic Test at DNA Labs UAE is 4400 AED. This investment can provide crucial information for affected individuals and their families, enabling them to understand their condition better and make informed decisions regarding care and management.
The "PLEC Gene Epidermolysis Bullosa Simplex with Pyloric Atresia Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE. This test specifically focuses on identifying mutations in the PLEC gene, which are known to cause a rare and severe form of epidermolysis bullosa simplex accompanied by pyloric atresia. Epidermolysis bullosa simplex is a group of genetic skin disorders characterized by fragile skin that blisters easily, while pyloric atresia is a congenital condition in which the opening from the stomach to the first part of the small intestine (the pylorus) is blocked or narrowed. The combination of these conditions represents a significant health challenge, necessitating early and accurate genetic diagnosis for effective management and treatment planning. The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, employing cutting-edge genetic analysis technologies to ensure high accuracy and reliability of the results.
The KRT14 gene plays a critical role in the health and stability of the skin. Mutations in this gene are associated with Epidermolysis Bullosa Simplex (EBS), a group of genetic conditions characterized by fragile skin that easily blisters and tears. Among the types of EBS, the autosomal recessive type 1 is particularly severe, with symptoms appearing at birth or early infancy.
The genetic test for this condition focuses on identifying mutations in the KRT14 gene to confirm a diagnosis of Epidermolysis Bullosa Simplex autosomal recessive type 1. This test is essential for early diagnosis, allowing for appropriate management and care strategies to be implemented, improving the quality of life for affected individuals.
DNA Labs UAE offers this specialized genetic test for individuals suspected of having this condition or for families with a history of EBS. The test is priced at 4400 AED, reflecting the intricate processes involved in genetic analysis and the critical information it provides for affected families. Conducted in a state-of-the-art laboratory by experienced geneticists, the test adheres to the highest standards of accuracy and reliability, ensuring families receive the crucial information needed for managing this challenging condition.
The DST Gene Epidermolysis Bullosa Simplex Autosomal Recessive Type 2 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the DST gene that are responsible for the autosomal recessive form of Epidermolysis Bullosa Simplex (EBS) type 2. This condition is a rare genetic disorder characterized by the formation of blisters and erosions on the skin in response to minor trauma or friction. The test is crucial for early diagnosis, enabling appropriate management and counseling for affected individuals and their families. The procedure involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific genetic mutations in the DST gene. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic markers associated with this condition. By opting for this test at DNA Labs UAE, individuals gain access to crucial information that can guide medical and personal decisions, offering a pathway to better understanding and managing Epidermolysis Bullosa Simplex.
The KRT14 Gene Epidermolysis Bullosa Simplex Dowling-Meara Type Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the KRT14 gene, which are associated with the Dowling-Meara type of Epidermolysis Bullosa Simplex (EBS-DM). This form of EBS is a rare genetic skin disorder characterized by the formation of blisters and erosions on the skin in response to minor injuries or friction. The condition is inherited in an autosomal dominant manner, meaning a mutation in just one of the two copies of the gene is enough to cause the disorder.
The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect the presence of specific mutations in the KRT14 gene. Identifying these mutations can confirm a diagnosis of EBS-DM, which is crucial for managing the condition, understanding the risk of passing it on to future generations, and potentially guiding treatment decisions.
The cost of the KRT14 Gene Epidermolysis Bullosa Simplex Dowling-Meara Type Genetic Test at DNA Labs UAE is 4400 AED. This cost reflects the specialized nature of the test, the expertise required to interpret the results, and the significant impact this diagnosis can have on patient care and family planning. By providing this test, DNA Labs UAE plays a vital role in the early identification and management of individuals with this challenging and rare condition.
The KRT14 Gene Epidermolysis Bullosa Simplex Koebner Type Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE. This test is designed to identify mutations in the KRT14 gene, which are responsible for causing Epidermolysis Bullosa Simplex (EBS), specifically the Koebner variant. EBS is a group of genetic conditions that result in fragile skin that easily blisters from minor injuries or friction. The Koebner type is characterized by widespread blistering that can occur anywhere on the body.
The test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for specific genetic alterations in the KRT14 gene. Identifying these mutations can confirm a diagnosis of EBS Koebner type, which is crucial for management and treatment planning. It can also provide important information for genetic counseling, especially for families with a history of the condition.
The cost of the KRT14 Gene Epidermolysis Bullosa Simplex Koebner Type Genetic Test at DNA Labs UAE is 4400 AED. This cost reflects the specialized nature of the test, which requires advanced genetic sequencing technologies and expert analysis to accurately identify the mutations associated with this condition.
The PLEC Gene Epidermolysis Bullosa Simplex Ogna Type Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, aimed at detecting mutations in the PLEC gene. These mutations are responsible for causing Epidermolysis Bullosa Simplex Ogna type, a rare genetic skin disorder characterized by blistering of the skin following minor injuries or friction. The condition is inherited in an autosomal dominant pattern, meaning that only one copy of the altered gene in each cell is sufficient to cause the disorder.
This genetic test involves analyzing the patient's DNA to identify any abnormalities in the PLEC gene that may lead to the development of the disease. By doing so, it provides crucial information for the accurate diagnosis and management of individuals and families affected by Epidermolysis Bullosa Simplex Ogna type. Early diagnosis through genetic testing can help in managing the symptoms, preventing complications, and providing genetic counseling for affected families.
The test is available at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the PLEC Gene Epidermolysis Bullosa Simplex Ogna Type Genetic Test is 4400 AED. This price may cover the laboratory procedures, analysis, and genetic counseling sessions that help patients and their families understand the test results and their implications.
